Zusammenfassung
Inhalationstherapie bedeutet heute die Behandlung des Atemwegstraktes mit einem Aerosol. Unter einem Aerosol versteht man ein 2-Phasen-System, welches aus einem Gas einerseits und Partikeln andererseits besteht, wobei die Partikel entweder fest (Suspensionsaerosol) oder flüssig (Lösungsaerosol) sein können (Newman u. Pavia 1985; Swift 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahmad D (1984) Effects of aerosol propellants on airways function. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Canada Ltd. pp 22–26
American Thoracic Society (1980) Guidelines for the use of intermittent positive pressure breathing (IPPB). Resp Care 25: 365–370
Andersen JB, Klausen NO (1982) A new mode of administration of nebulized bronchodilator in severe bronchospasm. Eur J Respir Dis (Suppl) 119: 97–100
Asmundsson T, Johnson RF, Kilbum KH, Goodrich JK (1973) Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis 108: 506–512
Auty RM, Brown K, Neale MG, Snashall PD (1987) Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the spinhaler. Br J Dis Chest 81: 371–380
Barnes KL, Clifford R, Holgate ST, Murphy D, Comber P, Bell E (1987) Bacterial contamination of home nebulisers. Br Med J 295: 812
Barnes PJ (1987) Pharmacology of the lower airways. In: Newman SP, Moren F, Crompton GK (eds) A new concept in inhalation therapy. Medioom pp 25–48
Barron EN (1988) Proper technique for using inhalers in asthma. N Engl J Med 316 (15): 951–952
Beasley CRW, O‘Donnell TV (1985) Pear shaped spacer nebuhaler compared with nebulised solution for terbutaline administration in acute severe asthma N Z Med J 98: 845–855
Beasley CRW, Rafferty P, Holgate ST (1987a) Bronchoconstrictor properties of preservatives in ipratropium bromide ( Atrovent) nebuliser solution. Br Med J 294: 1197–1198
Beasley CRW, Rafferty P, Holgate ST (1987b) (Correspondence) Paradoxical response to nebulised salbutamol in wheezy infants. Thorax 42: 702–703
Beasley CRW, Rafferty P, Holgate ST (1988) Adverse reactions to the non-drug constituents of nebuliser solutions. Br J Clin Pharmacol 25: 283–287
Becker AB, Simons FER, Benoit TC, Gillespie CA (1985) Terbutaline by metered-dose inhaler: conventional inhaler versus tube spacer for children with asthma. Ann Allergy 55: 724–728
Bell KA, Ho AT (1981) Growth rate measurements of hygroscopic aerosols under conditions simulating the respiratory tract. J Aerosol Sci 12 (3): 247–254
Berdel D, v Berg A (1986) Bronchospasmolytische Wirkung von Fenoterol and Ipratropiumbromid als Einzelsubstanz sowie in der fixen Kombination nach bukkaler Anwendung mittels Dosier-Aerosol bei Kindern. Atemw Lungenkrkh 12 (6): 262–265
Berman DA, Noris R (1988) Inhaled bronchodilators in young pediatric asthmatic: a method of delivery. Am J Emerg Med 6 (2): 206
Birk Madsen E, Bundgaard A, Hidinger KG (1982) Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution. Eur J Clin Pharmacol 23: 27–30
Blackhall MI, O‘Donnell SR (1987) A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children. Eur J Respir Dis 71: 96–101
Bloomfield P, Crompton GK (1979) A tube spacer to improve inhalation of drugs from pressurized aerosols. Br Med J 12 /8: 1479
Botman MJ, de Krieger RA (1987) Contamination of small-volume medication nebulizers and its association with oropharyngeal colonization. J Hosp Infect 10: 204–208
Bouchikhi A, Becquemin MH, Bignon J, Roy M, Teillac A (1988) Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways. Eur Respir J 1: 547–552
Boye NP. Komstad S (1983) A comparison of fenoterol powder capsules and fenoterol metered dose spray in bronchial asthma. Eur J Respir Dis 64 (Suppl 130): 9–11
Brain JD, Valberg PA (1979) Deposition of arerosol in the respiratory tract. Am Rev Respir Dis 120: 1325–1373
Brain JD, Valberg PA, Sneddon S (1985) Mechanisms of aerosol deposition and clearance. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principle, diagnosis and therapy. Elsevier Sc (Biomed Divi), Amsterdam, 123–147
Brennan PO (1983) (Correspondence) - Addiction to aerosol treatment. Br Med J 287:1877
Brown A Jr, Schanker LS (1983) Absorption of aerolized drugs from the rat lung. Drug Metab Dispos 11 (4): 355–360
Bryant DH, Pepys J (1976) Bronchial reactions to aerosol inhalant vehicles. Br Med J May 29: 1319–1320
Burton AJ (1984) Asthma inhalation devices: what do we know? Br Med J 288: 1650–1651
Byron PR, Davis SS; Bubb MD, Cooper P (1977) Pharmaceutical implications of particle growth at high relative humidities. Pestic Sci 8: 521–526
Canny GJ, Levison H (1988) Aerosols–therapeutic use and delivery in childhood asthma. Ann Allergy 60: 11–19
Chambers S, Dunbar J, Taylor B (1980) Inhaled powder compared with aerosol administration of fenoterol in asthmatic children. Br J Arch Dis Children, 55: 73–74
Chung KF, Jeyasingh K, Snashall PD (1988) Influence of airway calibre on the intrapulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J 1: 890–895
Cissik JH, Bode FR, Smith JA (1986) Double-blind crossover study of five bronchodilator medications and two delivery methods in stable asthma. Chest 90 (4): 489–493
Clarke SW (1988) Inhaler therapy. Quar J Med (N S)67, 253: 355–368
Clarke SW, Newman SP (1981) Differences between pressurized aerosol and stable dust particles. Chest 80 (6): 907–909
Clarke SW, Pavia D, Newman SP (1982) Influence of different inhalation modes on the efficacy of pressurized aerosol bronchodilators. EurJ Respir Dis [Suppl 119] 63: 79–80
Clay MM, Clarke SW (1987) Effect of nebulised aerosol size on lung deposition in patients with mild asthma. Thorax 42: 190–194
Clay MM, Pavia D, Nemwan SP, Clarke SW (1982) Efficiency of jet nebulisers in the production of therapeutic aerosols. Thorax 37: 788–789
Clay MM, Pavia D, Newman SP, Lennard-Jones T, Clarke SW (1983) Assessment of jet nebulisers for lung aerosol therapy. Lancet Sept 10: 592–594
Coady TJ, Davies HJ, Barnes P (1976a) Evaluation of a breath actuated pressurized aerosol. Clin Allergy 6: 1–6
Coady TJ, Stewart CJ, Davies HJ (1976b) Synchronization of bronchodilator release. Practitioner 217: 273–275
Connolly CK (1975) Method of using pressurized aerosols. Br Med J July 5: 21
Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M (1982) Design and characteri- stics of a breath actuated, particle size selective medical aerosol inhaler. J Aerosol Sci 13 (1): 1–7
Crimi N, Palermo F, Cacopardo B, Vancheri C, Oliveti R, Palermo B, Mistretta A (1987) Bronchodilator effect of aerochamber and inspirease in comparison with metered dose inhaler. Eur J Respir Dis 71: 153–157
Crompton GK (1971) Breath-activated Aerosol. Br Med J June 12: 652
Crompton GK (1982a) Problems patients have using pressurized inhalers. Eur J Respir Dis [Suppl 119] 63: 101–104
Crompton GK (1982b) Sputum viscosity and long-term ipratropium bromide nebuliser therapy. Lancet May 29:1243
Crompton GK (1982c) Inhalation devices. Eur J Respir Dis 63: 489–492
Crompton GK (1988) New inhalation devices. Eur Respir J 1: 679–680
Cushley MJ, Lewis RA, Tattersfield AE (1983) Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax 38: 908–913
Dale BAS (1987) Bacterial contamination of home nebulisers. Br Med J 295: 1486
Davies DS (1975) Pharmacokinetics of inhaled substances. Postgraduate Med J 51 [Suppl]: 69–75
Davies DS (1982) Pharmacokinetic studies with inhaled drugs. Eur J Respir Dis [Suppl 119] 63: 67–72
Davis SS (1978) Physico-chemical studies on aerosol solutions for drug delivery. I. Water-propylen glycol systems. Int J Pharm 1: 71–83
Dirksen H, Groth S (1983) Fenoterol inhalation powder as an alternative to treatment with the metered dose inhaler. Eur J Respir Dis 64 [Suppl 1301: 48–53
Dirksen H, Groth S, Mygind N (1983) The bronchodilating effect of fenoterol after intranasal administration. Eur J Respir Dis 64 [Suppl 1281: 116–118
Dolovich M (1984) Lung deposition of aerosols: methods and assessments. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Canada Ltd, pp 27–37
Dolovich M, Ruffin RE, Roberts R, Newhouse MT (198la) Optimal delivery of aerosols from metered dose inhalers. Chest 80 (6):911–915
Dolovich M, Ryan G, Newhouse MT (1981b) Aerosol penetration into the lung–influence on airway responses. Chest 80 (6): 834–836
Dolovich M, Ruffin RE, Corr D, Newhouse MT (1983) Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 81 (1): 36–41
Dolovich M, Vanzieleghem M, Hidinger KG (1988) Influence of inspiratory flow rate on the response to terbutaline sulphate inhaled via the turbuhaler. Am Rev Respir Dis 137 (4): 433
Duncan D, Paterson IC, Harris D, Crompton GK (1977) Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional pressurised aerosol. Br J Clin Pharmacol 4: 669–671
Durrani FK, Richards W, CHurch JA, Roberts MJ, Keens TG (1988) Evaluation of a new, shorter method of administration of drenergic aerosols in the treatment of asthma. Ann Allergy 61: 147–150
Earis JE, Bernstein A (1978) Misuse of pressurised nebulisers. Br Med J June 10: 1554
Editorial (1975) Fluorocarbon aerosol propellants. Lancet May 10: 1073
Editorial (1978) Wet or dry inhalers? Lancet Jan 14: 79–80
Editorial (1981) The proper use of aerosol bronchodilators. Lancet Jan 3: 23
Editorial (1984) The nebuliser epidemic. Lancet Oct 6: 789
Editorial (1988) Nebulizers and paradoxical bronchoconstriction. Lancet July 23: 202
Eedy DJ, Barton K, Stanford CF (1988) Irritant contact facial dematitis due to nebulize therapy. Postgr Med J 64: 306–307
Ellul-Micallef R, Moren F, Wetterlin K, Hidinger KC (1980) Use of a special inhaler attachment in astmatic children. Thorax 35: 620–623
Emmett PC, Aitken RJ, Hannan WJ (1982) Measurements of the total and regional deposition of inhaled particles in the human respiratory tract. J Aerosol Sci 13 (6): 549–560
Engel T, Reinig JH, Mailing HJ, Scharling B, Nihander K, Madsen F (1989) Clinical comparison of inhaled budenoside delivered either via presserized metered dose inhale or Tubuhah. Allergy 44: 220–225
Epstein SW, Duncan CS (1984) The use of MDI‘s in clinical medicine. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Ltd. Canada, pp 59–62
Epstein SW, Manning CPR, Ashley MJ, Corey PN (1979) Survey of the clinical use of pressurised aerosol inhalers. Can Med Assoc J 120: 813–816
Epstein SW, Parsons JE, Corey PN, Worsley GH, Reilly PA (1983) A comparison of three means of pressurized aerosol inhaler use. Am Rev Respir Dis 128: 253–255
Eschenbacher WL, Boushey HA, Sheppard D (1984) Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permanent anion causes cough alone. Am Rev Respir Dis 129: 211–215
Exner M, Vogel F, Rost HD (1983) Mikroorganismen in Inhalationsgeräten der Heimtherapie. Dtsch Med Wochenschr 108: 12–17
Fairchild CI, Stampfer JF (1987) Particle concentration in exhaled breath. Am Ind Hyg Assoc J 48 (11): 948–949
Fairshter RD (1987) Evaluation of a metered-dose aerosol delivery system using partial flow-volume curves. Am Rev Respir Dis 135: 741–743
Ferron GA (1977) The size of soluble aerosol particles as a function of the humidity of the air. Application to the human respiratory tract. J Aerosol Sci 8: 251–267
Fern GA, Kerrebijn KF, Weber J (1976) Properties of aerosols produced with three nebulizers. Am Rev Respir Dis 114: 899–908
Freelander M, Van Asperen PP (1984) Nebuhaler versus nebuliser in children with acute asthma. Br Med J 288: 1873–1874
Fuglsang G, Pedersen S (1986) Comparison of nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis 69: 109–113
Fuller HD (1986) Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique. Can Med Assoc J 135: 625–629
Gerrity TR, Garrard CS, Yeates DB (1981) Theoretic analysis of sites of aerosol deposition in the human lung. Chest 80 (6): 898–901
Gervais A, Begin P (1987) Bronchodilatation with a metered-dose inhaler plus an extension using tidal breathing vs jet nebulization. Chest 92 (5): 822–824
Gleeson JGA, Price JF (1988) Controlled trial of budenoside given by the nebuhaler in preeschool children with asthma. Br Med J 297: 163–166
Godden DJ, Crompton GK (1981) An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficiently. Br J Dis Chest 75: 165–168
Gomm SA, Keaney NP, Hunt LP, Allen SC, Stretton TB (1983) Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation. Thorax 38: 297–301
Gurwitz D, Levison H, Mindorff C, Reilly P, Worsley G (1983) Assessment of a new device ( Aerochamber) for use with aerosol drugs in asthmatic Children. Ann Allergy 50: 166–170
Hampson NB, Mueller MP (1989) (Correspondence) Cooling of metered-dose inhalers decreases pressure output from canisters. New Engl J Med 320 (5):321
Hausen T (1984) Inhalationsbehandlung bei chronischen Atemwegserkrankungen. Therapiewoche 34: 1309–1315
Hausen T (1986) Worauf Sie bei der Verordnung achten müssen.–Umgang mit Dosier-Aerosolen and Inhaliergeäten bei obstruktiven Atemwegserkrankungen. Der Allgemeinarzt 8 (8): 1138–1150
Henry RL, Milner AD, Davies JG (1983) Simple drug delivery system for use by young asthmatics. Br Med J 286: 2121
Hetzel MR, Clark TJH (1977) Comparison of salbutamol Rotahaler with conventional pressurized aerosol. Clin Allergy 7: 563–568
Heyder J (1981) Mechanisms of aerosol particle deposition. Chest 80 (6): 820–823
Heyder J (1982) Particle transport onto human airway surfaces. Eur J Respir Dis [Suppl 119] 63: 29–55
Hidinger KG, Perk J (1981) Clinical trial of a modified inhaler for pressurized aerosols. Eur J Clin Pharmacol 20: 109–111
Higgs CMB, Jones P, Transer AR (1987) Bacterial contamination of home nebulisers. Br Med J 295: 1281–1282
Hill LS (1988) The inhaled route of drug administration in the therapy of asthma. Br J Clin Prac 42 (8): 313–315
Hiller C, Mazumder MK, Wilson JD, Bone RC (1978) Aerodynamic size distribution of metered-dose bronchodilator aerosols. Am Rev Respir Dis 118: 311–317
Hiller C, Mazumder MK, Wilson JD, Renninger RG, Bone RC (1981) Physical properties of therapeutic aerosols. Chest 80 (6): 901–903
Hodges IGC, Milner AD, Stokes GM (1981) Assessment of a new device for delivering aerosol drugs to asthmatic children. Arch Dis Child 56: 787–800
Horsley MG, Bailie GR (1988) Rish factors for inaedequate use of pressurized aerosol inhalers. J Clin Pharm Ther 13: 139–143
Houlsby WT, Bannister OM (1987) Teaching young asthmatics to use inhalers. The Practitioner 231: 362
Itoh H, Ishii Y, Meda H, Todo G, Torizuka K, Smaldone GC (1981) Clinical observations of aerosols deposition in patients with airways obstruction. Chest 80 (6): 837–840
Johansen B (1982) Closing remarks. Eur J Respir Dis [Suppl 119] 63: 123–125
Johnsen CR, Weeke ER (1988) Turbuhaler: a new device for dry powder turbutaline inhalation. Allergy 43: 392–395
Jenkins SC, Heaton RW, Fulton TJ, Moxham J (1987) Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest 91 (6): 804–807
Jones PD, Moritz V, Pierce RJ (1985) Microbial contamination of domiciliary nebuliser therapy equipment. Aust NZ J Med 15: 585–589
Kim CS, Trujillo D, Sackner MA (1985) Size aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 132: 137–142
Kim CS, Eldridge MA, Sackner MA (1987) Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 135: 157–164
Kitzman DW (1988) Inhalers and cold weather. North Carolina Med J 49 (2): 109
Kjellman B (1982) Inhalation therapy in children Eur J Respir Dis [Suppl 119] 63: 115–119
Kjellman NIM (1981) Letter to the editor. Allergy 36: 437–438
Kjeflman NIM, Hidinger KG (1981) Improved efficacy of pressurized terbutaline aerosol in childhood asthma using a spacer. Opuscula Medica 26 (2): 47–48
Klein G, Köhler D, Fleischer D, Zähringer T, Matthys H (1984) Gibt es Wirkungsunterschiede auf die bronchiale Obstruktion zwischen totaler und intrabronchialer Deposition von 200 ug Fenoterol? Verh Dtsch Ges Inn Med 90: 1096–1098
Klein G, Köhler D, Matthys H (1988) Unterschiedliche Reaktion des Bronchialsystems auf zentrale oder periphere Inhalation eines Parasympathomimetikums. Atemw Lungenkrkht 14 (7): 313–316
Köhler D (1988) Vor-und Nachteile verschiedener Inhalationsgeräte. Dtsch Ärztebl 31 (3):C-79 - C-81
Köhler D, Simonides R, Rothfuss J, Vatsag E, Daikeler G, Matthys H (1983) Aerosolverteilungsmuster von 16 handelsüblichen Inhalationsgeräten. Prax Klin Pneumo137: 922–924
Köhler D, Fleischer W, Schiimichen C, Matthys H (1985) Depositionsmuster von Dosieraerosol im menschlichen Organismus. Atemw Lungenkrkht 11 (7): 340–341
Köhler D, Fleischer W, Matthys H (1986) Inhalationstherapie. Gedon & Reuss, München
Köhler D, Fleischer W, Matthys H (1988) New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99 m. Respiration 53: 65–73
König P (1985) Spacer devices used with metered-dose inhalers–breakthrough or gimmick? Chest 88 (2): 276–284
König P, Gayer D, Kantak A, Kreutz C, Douglass B, Hordvik NL (1988) A trial of metaproterenol by metered-dose inhaler and two spacers in preeschool asthmatics. Pediatr Pulmonol 5: 247–251
Komstad S, Boye NP (1983) Patient errors and preference with regard to the use of a bronchodilating spray and fenoterol (Berotec) powder. EurJ Respir Dis 64 ISuppl 1301: 12–16
Landensuo A, Muittari A (1986) Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis 68: 225–332
Latimer KM, Roberts R, Dolovich J, Hargreave FE (1982) Salbutamol: comparison of bronchodilating effect of inhaled powder and aerosol in asthmatic subjects. Can Med Assoc J 127: 857–859
Laursen LC (1986) A new inhalation technique for improved effect of aerolized drugs in asthma. Allergy 41: 157–159
Lawford P, McKenzie D (1981) Pressurized aerosol technique. Lancet May 2: 1003–1004
Lawford P, McKenzie D (1983) Pressurized aerosol inhaler technique: How important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs? Br J Chest 77: 276–281
Lee HS (1983) Proper aerosol inhalation technique for delivery of asthma medications. Clin Pediatr 22 (6): 440–443
Lee HS, Evans HE (1984) Aerosol bag for administration of bronchodilators to young asthmatic children. Pediatrics 73 (2): 230–232
Lee HS, Evans HE (1987a) Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest 91 (3): 366–369
Lee HS, Evans HE (19876) Aerosol inhalation teaching device. J Pediatr 110: 249–252
Levison H, Reilly PA, Worsley GH (1985) Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr 107 (5) 662–668
Lewis RA, Fleming JS (1985) Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. Br J Chest 79: 361–367
Lindemann H (1983) Die Inhalationsbehandlung in der kinderärztlichen Praxis. Pädiat Prax 28: 449–459
Lindgren SB, Bake B, Larsson S (1987) Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis 70: 93–98
Lindgren SB, Formgren H, Moren F (1980) Improved aerosol therapy of asthma: effect of actuator tube size on drug availability. Eur J Respir Dis 61: 56–61
Löllgen H, v. Nieding G, Krekeler H (1978) Zur bronchialerweitemden Wirkung ß-adrenerger Substanzen bei oraler, bukkaler und inhalativer Anwendung. Atemw Lungenkrkht 4 (6): 401–404
Loren M, Chai H, Miklich D, Barwise G (1977) Comparison between simple nebulization and intermittent positive-pressure in asthmatic children with severe bronchospasm. Chest 72 (2): 145–147
Lowry RH, Wood Am, Higenbottam TW (1988) Effects of pH and osmolarity on aerosol-induced cough in normal volunteers. Clin Sci 74: 373–376
MacFarlane JT, Lane DJ (1980) Irregularities in the use of regular aerosol inhalers. Thorax 35: 477–478
Maddem PJ, Oh TE, Elphick HR, Paterson JW (1978) Adverse reaction after aerosol inhalation. Med J Aust 1: 274–275
Mallol J, Barmeto L, Girardi G, Toro O (1987) Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: Use of MDI with a spacer device. Pediatr Pulmonol 3: 352–356
Marion RJ, Creer TL, Bums K (1983) Training asthmatic children to use their nebnlizPr correctly. J Asthma 20 (3): 183–188
Matthys H, Köhler D (1985) Pulmonary deposition of aerosols by different mechanical devices. Respiration 48: 269–276
Matthys H, Köhler D (1988) Aerosoltherapie. Prax Kim Pneumol 42: 314–319
Matthys H, Eltschka R, App EM (1988) Deposition eines markierten B2-Sympathomimetikum-Aerosols. Atemw Lungenkrkht 14 (10): 485–488
McCarthy TP (1988) (Correspondence) Nebulised budenoside in severe childhood asthma. Lancet February 18:379–380
McLean AEM (1977) Chlorofluorocarbons–in the can, in man an in the atmosphere. Br J Clin Pharmacol 4: 663–666
Milner AD (1986) (Correspondence) Nebulisers - uses and abuses. Arch Dis Child 61:1142–1148
Mitchell DM, Solomon MA, Tolfree SEJ, Short M, Spiro SG (1987) Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax 42: 457–461
Molina MJ, Rowland FS (1974) Stratospheric sink for chlorofluoromethanes: chlorine atom catalysed destruction of ozone. Nature 249: 810–812
Moren F (1978a) Drug deposition of pressurized inhalation aerosols. I. Influence of actuator tube design. Int J Phann 1: 205–212
Moren F (1978b) Drug deposition of pressurized inhalation aerosols, II. Influence of vapour pressure and metered volume. Int J Pharm 1: 213–218
Moren F (1982) Drug deposition of pressurized inhalation aerosols. Eur J Respir Dis [Suppl 119] 63: 51–55
Moren F (1984) Formulation and design of metered dose inhalers. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Canada Ltd, pp 1–5
Moren F (1985) Aerosol dosage forms and formulations. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, Diagnosis and therapy. Elsevier Sci (Biomed Div); Amsterdam 261–287
Moren F, Andersson J (1980) Fraction of dose exhaled after administration of pressurized inhalation aerosols. Int J Pharm 6: 295–300
Moren F, Andersson J, Stiksa G (1984) Mode of inhalation for trained and untrained asthmatics using a pressurized aerosol. Respiration 45: 56–60
Morgan MDL, Singh BV, Frame MH, Williams SJ (1982) Terbutaline aerosol given through pear spacer in acute severe asthma Br Med J 285: 849–850
Morrison-Smith J, Gwynn CM (1978) A clinical comparison of aerosol and powder administration of beclomethason dipropionate in asthma. Clin Allergy 8: 479–481
Morrow PE, Yu CP (1985) Models of aerosol behavior in airways. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, diagnosis and therapy. Elsevier Sci (Biomed Div) Amsterdam, pp 149–191
Newhouse MT (1984) Metered dose inhaler aerosol propellants. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Canada Ltd. pp 6–18
Newhouse MT, Dolovich M (1986a) Control of asthma by aerosols. N Engl J Med 315 (14): 870–874
Newhouse MT, Dolovich M (1986b) Spacer devices for asthma. J Pediatr 109 (5): 913
Newhouse MT, Dolovich M (1986c) Aerosol therapy of asthma: Principles and applications. Respiration 50 [Suppl] 21: 123–130
Newhouse MT, Dolovich M (1987a) Aerosol therapy: Nebulizer vs metered dose inhaler. Chest 91 (6): 799–800
Newhouse MT, Dolovich M (1987b) Aerosol therapy of reversible airflow obstruction. Chest 91 (5) [Suppl]: 58S - 64S
Newhouse MT, Ruffin RE (1978) Deposition and fate of aerosolized drugs. Chest 73 (6): 936–943
Newman SP (1983) Deposition and effects of inhalation aerosols. AB DRACO, Lund Sweden
Newman SP, Clarke SW (1985) Aerosols in therapy. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, diagnosis and therapy. Elsevier Sci Publ (Biomed Div), Amsterdam, pp 289–312
Newman SP, Pavia D (1985) Aerosol deposition in man. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, diagnosis and therapy. Elsevier Sci (Biomed Div), Amsterdam, pp 193–217
Newman SP, Pavia D, Clarke SW (1980) Simple instructions for using pressurised aerosol bronchodilators. J R Soc Med 73: 776–779
Newman SP, Pavia D, Clarke SW (1981a) Improving the bronchial deposition of pressurized aerosols. Chest 80 (6): 909–911
Newman SP, Pavia D, Clarke SW (198lb) How should a pressurized B-adrenergic bronchodilator be inhaled? Eur J Respir Dis 62: 3–21
Newman SP, Moren F, Pavia D, Little F, Clarke SW (1981c) Deposition of pressurized suspension aerosols inhaled through extension Devices. Am Rev Respir Dis 124: 317–320
Newman SP, Pavia D, Garland N, Clarke SW (1982) Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis [Suppl 119] 63: 57–65
Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW (1984a) Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 39: 935–941
Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW (1984b) Improved pressurised aerosol deposition pattern with the Nebuhaler spacer. Am Rev Respir Dis 129: 4
Newman SP, Moren F, Trofast E, Woodman G, Clarke SW (1987a) Deposition patterns in man from turbuhaler: a preliminary report. In: Newman SP, Moren F, Crompton GK (eds) A new concept in inhalation therapy. Medicom, pp 104–114
Newman SP, Pellow PGD, Clarke SW (1987b) In vitro comparison of deVilbiss jet and ultrasonic nebulizers. Chest 92 (6):991–994
Newman SP, Johnson MA, Clarke SW (1988) (Correspondence) - Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax 43: 159
Newman SP, Moren F, Trofast E, Talaee N, Clarke SW (1989) Deposition and clinical efficacy or terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J 2: 247–252
Nieminen MM, Holli H, Landensuo A, Muittari A, Karvonen J (1987) Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis 71: 145–152
Nilsson HT, Simonsson BG, Strom B (1975) The fate of 3H-terbutaline sulphate administered to man as an aerosol. Eur J Clin Pharmacol 10: 1–7
Nolte D, Berger D, Förster E (1979) Wirken Treibgase von Dosier-Aerosolen bronchokonstriktorisch? Dtsch Med Wochenschr, 104: 172–174
O‘Callaghan C, Milner AD (1986) Pradoxial deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet Dec 20: 1424–1425
O‘Callaghan C, Milner AD (1987) Paradoxical response to nebulised salbutamol in wheezy infants. Thorax 42: 702–703
O‘Callaghan C, Milner AD (1988) Aerosol treatment abuse. Arch Dis Child, 63: 70
Oherek J, Gayrard P, Grimaud C, Charpin J (1976) Patient error in use of bronchodilator metered aerosols. Br Med J 1: 76
Paterson IC, Crompton GK (1976) Use of pressurised aerosols by asthmatic patients. Br Med J Jan 10: 76–77
Pauwels R (1985) Pharmacokinetics of inhaled drugs. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, diagnosis and therapy. Elsevier Sci (Biomed Div), Amsterdam, pp 219–224
Pauwels R, Lamont H, Hidinger K, Straetenvd M (1984) Influence of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler. Respiration 45: 61–66
Pavia D, Thomson ML, Clarke SW, Shannon HS (1977) Effect of lung function and mode of inhalation om penetration of aerosol into the human lung. Thorax 32: 194–197
Pavia D, Thomson ML, Clarke SW (1978) Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis 117: 199–203
Pavia D, Lopez-Vidriero MT, Sutton PP, Clarke SW (1982) Long-term ipratropium bromide nebuliser therapy and lung mucociliary clearance. Lancet 2: 332–333
Pavia D, Agnew JE, Lopez-Vidriero MT, Newman SP, Clarke SW (1984) The effect of metered dose aerosols on the viscoelastic properties and clearance of bronchial secretions. In: Epstein SW (ed) Metered dose inhalers. Astra Pharmaceuticals Canada Ltd, pp 38–48
Pedersen S (1983) Aerosol treatment of bronchoconstriction in children, with or without a tube spacer. N Engl J Med 308 (22): 1328–1330
Pedersen S (1985a) Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and a dry powder inhaler. Allergy 40: 300–304
Pedersen S (1985b) Optimal use of tube spacer in asthmatic children. Clin Allergy 15: 473–478
Pedersen S (1986a) How to use a rotahaler. Arch Dis Child 61: 11–14
Pedersen S (1986b) The importance of a pause between the inhalation of two puffs of terbutaline from a pressurized aerosol with a tube spacer. J Allergy Clin Immunol 77 (3):505–509
Pedersen S (1987) Inhaler use in children with asthma. Dan Med Bull 34 (5): 234–249
Pedersen S, Prahl P (1987) Jet-nebulized beclomethasone dipropionate in the management of bronchial asthma. Allergy 42: 272–275
Pedersen S, Steffensen G (1986a) Simplification of inhalation therapy in asthmatic children. Allergy 41: 296–301
Pedersen S, Steffenson G (1986b) Fenoterol powder inhaler technique in children: influence of inspiratory flow rate and breath-holding. Eur J Respir Dis 68: 207–214
Pedersen S, Frost L, Amfred T (1986) Errors in inhalation technique and efficinecy in inhaler use in asthmatic children. Allergy 41: 118–124
Persson G, Gruvstad E, Stahl E (1988) A new miltiple dose powder inhaler, ( Turbuhaler), compared with a pressurized inhaler in a study of terbutaline in asthmatics. Eur Respir J 1: 681–684
Pierce Ak, Sanford JP, Thomas GD, Leonard JS (1970) Long-term evaluation of decontamination of inhalation-therapy equipment and the occurence of necotizing pneumonia. N Engl J Med 282 (10): 528–531
Pool JB, Greenough A, Gleeson JGA, Price IF (1988) Inhaled bronchodilator treatment via the nebuhaler in young asthmatic patients. Arch Dis Child, 63: 288–291
Polli GP, Grim WM, Bacher FA, Yunker MH (1969) Influence of formulation on aerosol particle size. J Phann Sci 58 (4): 484–486
Pover GM, Langdon CG, Jones SR, Fidler C (1988) Evaluation of a breath operated powder inhaler. J Int Med Res 16: 201–203
Prahl P, Jensen T (1987) Decreased adreno-cortical suppression utilizing the nebuhaler for inhalation of steroid aerosols. Clin Allergy 17: 393–398
Pratt HF (1982) Abuse of salbutamol inhalers in young people. Clin Allergy 12: 203–208
Prendiville A, Green S, Silverman M (1987) Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 42: 86–91
Pritchard JN (1987) Particle growth in the airways and the influence of airflow. In: Newman SP, Moren F, Crompton GK (eds) A New Concept in Inhalation Therapy. Medicom, pp 3–24
Rachelefsky GS, Rohr AS, Wo J, Gracey V, Spector SL, Siegel SC, Katz RM, Mickey MR (1986) Use of a tube spacer to improve the efficacy of a metered-dose inhaler in asthmatic children. Am J Dis Child 140: 1191–1193
Rao S, Wilson DB, Brooks RC, Sproule BJ (1970) Acute effects of nebulization of N-acetylcystein on pulmonary mechanics and gas exchange. Am Rev Respir Dis 102: 17–22
Rees PJ, an TM, Moren F (1982) The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis [Suppl 119[63: 73–78
Reiser J, Warner JO (1986) Inhalation treatment for asthma. Arch Dis Child 61: 88–94
Reiser J, Frame MH, Warner JO (1986) The potential value of a 750-ml spacer for the administration of inhaled corticosteroids to children. Pediatr Puhnonol 2: 237–243
Richards R, Simpson SF, Renwick AG, Holgate ST (1988) Inhalation rate of sodium cromoglycate determines plasma phannakokinetics and protection against AMP-induced bronchoconstriction in asthma. Eur Respir J 1: 896–901
Riley DJ, Weitz BW, Edelman NH (1976) The response of asthmatic subjects to isoproterenol inhaled at differing lung volumes. Am Rev Respir Dis 114: 509–515
Riley DJ, Liu RT, Edelman NH (1979) Enhanced responses to aerolized bronchodilator therapy in asthma using respiratory maneauvers. Chest 76 (5): 501–507
Rivlin J, Mindorff C, Levison H, Kazim F, Reilly P, Worsley G (1983) Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler. J Pediatr 102 (3): 470–472
Rivlin J, Mindorff C, Reilly P, Levison H (1984) Pulmonary response to a bronchodilator delivered from three inhalation devices. J Pediatr 104 (3): 470–473
Rodenstein D, Stanescu DC (1982) Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest 76: 365–373
Rothe T, Mansfeld H-J, Schmitz-Schumann M (1988) Dosieraerosole in der Behandlung des kindlichen Asthma bronchiale. Der Kinderarzt 19 (5): 679–684
Ruffin RE, Montgomery JM, Newhouse MT (1978a) Site of beta-adrenergic receptors in the respiratory tract. Chest 74 (3): 256–260
Ruffin RE, Obminsky G, Newhouse MT (1978b) Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax 33: 689–693
Ruffin RE, Dolovich MB, Wolff RK, Newhouse MT (1978c) The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis 117: 485–492
Ruffin RE, Kenworthy MC, Newhouse MT (1978d) Response of asthmatic patients to fenoterol inhalation: A method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther 23 (3): 338–345
Russell G, Frame M (1986) Terbutaline by Nebuhaler in young children. The Practitioner 230: 1043–1046
Russi E (1983) Aerosoltherapie. Schweiz Med Wochenschr 113 (35): 1234–1238
Russi E (1985) Praktische Aspekte der Inhalationstherapie mit Aerosolen. Schweiz Rundschau Med (Praxis) 74 (9): 207–210
Ryan G, Dolovich MB, Obminski G, Cockroft DW, Juniper E, Hargreave FE, Newhouse MT (1981) Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol 67 (2): 156–161
Ryrfeldt A (1987) Pharmacokinetic aspects of drugs for inhalation. In: Newman SP, Moren F, Crompton GK (eds) A new concept in inhalation therapy. Medicom, pp 49–64
Sackner MA, Epstein S, Wanner A (1976) Effect of beta-adrenergic agonists aerolized by freon propellant on tracheal mucous velocity and cardiac output. Chest 69 (5): 593–598
Sackner MA, Brown LK, Kim CS (1981) Basis of an improved metered aerosol delivery system. Chest, 80 (6): 915–918
Salorinne Y, Siren R (1983) Ventilation effects of fenoterol powder and freon-propelled aerosol in patients with asthma. Eur J Respir Dis 64 [Suppl 130]: 6–8
Salzman GA, Pryszczynski DR (1988) Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with aerochamber. J Allergy Clin Immunol 81: 424–428
Saunders KB (1965) Misuse of inhaled bronchodilator agents. Br Med J 1: 1037–1038
Schanker LS (1978) Drug absorption from the lung. Biochem Pharmacol 27: 381–385
Schön MH, Bruderer K (1988) Der Einfluß hyperosmolarer Mischlösungen von Natriumchlorid and ß2Sympathomimetika auf die Lungenfunktion von asthmatischen Kindern and Adoleszenten. Schweiz Med Wochenschr 118: 1377–1381
Seifert CF, Hamilton SF (1988) Incorrect instructions for use of metered-dose inhalers. Am J Hosp Pharm 45: 75–76
Sheppard D, Rizk NW, Boushey HA, Bethel RA (1983) Mechanism of cough and bronchoconstriction induced by destilled water aerosol. Am Rev Respir Dis 127: 691–694
Shim C (1987) Inhalation aids of metered dose inhalers. Chest 91 (3): 315–316
Shim C, Williams MH (1980) The adequacy of inhalation of aerosol from canister nebulizers. Am J Med 69: 891–894
Shore SC, Weinberg EG, Dun MH (1976) Buccal administration of fenoterol aerosol in young children with asthma. S Mr Med J 50: 1362–1364
Simonsson BG (1982) Anatomical and pathophysiological considerations in aerosol therapy. Eur J Respir Dis [Suppl 119] 63: 7–14
Smith G, Hiller C, Mazumder M, Bone R (1980) Aerodynamic size distribution of cromolyn sodium at ambient and airway humidity. Am Rev Respir Dis 121: 513–517
Speizer FE, Wegman DH, Ramirez A (1975) Palpitation rates associated with fluorocarbon exposure in a hospital setting. N Engi J Med March 20: 624–626
Stauder J, Hidinger K-G (1983) Terbutaline aerosol from a metered dose inhaler with a 750-ml spacer or as a nebulized solution. Respiration 44: 237–240
Steventon RD; Wilson RSE (1981) Facemask or mouthpiece for delivery of nebulized bronchodilator aerosols? Br J Dis Chest 75: 88–90
Stiftung Warentest (1983) Test Inhaliergeräte. Viel Dampf–selten Wirkung. Test 18 (6): 32–37
Stiksa G (1982) Indications for continuous aerosol therapy. Eur J Respir Dis [Suppl 119] 63: 89–96
Svedmyr N, Löfdahl CG, Svedmyr K (1982) The effect of powder aerosol compared to pressurized aerosol. Eur J Respir Dis [Suppl 119] 63: 81–88
Swift DL (1985) Aerosol characterization and generation. In: Moren F, Newhouse MT, Dolovich MB (eds) Aerosols in medicine. Principles, diagnosis and therapy. Elsevier Sci (Biomed Div), Amsterdam, pp 53–76
Teo J, Kwang LW, Yip WCL (1988) An inexpensive spacer for use with metered-dose bronchodilators in young asthmatic children. Pediatr Pulmonol 5: 244–246
Thiessen B, Pedersen OF (1980) Effect of freon inhalation on maximal expiratory flows and heart rhythm after treatment with salbutamol and ipratropium bromide. Eur J Respir Dis 61: 156–161
Thomas SHL, Langford JA, George RDG, Geddes DM (1988) Improving the efficiency of drug administration with jet nebulizers. Lancet Jan 16: 126
Thompson PJ, Dhillon P, Cole P (1983) Addication to aerosol treatment: the asthmatic altemative to glue sniffing. Br Med J 287: 1515–1516
Toogood JH (1986) (Correspondence) - Are spacers of any use in the treatment of asthma? Pediatr Pulmonol 2 (4):250–251
Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson S (1984) Use of spacers to facilitate inhaled conicosteroid treatment of asthma. Am Rev Respir Dis 129: 723–729
Ulmer WT, Islam MS, Zimmermann I, Bulgalho De Almeida AA (1982) Aggression and Abwehr am Beispiel der Lunge. Gemischte Abwehr: Die Atemwegsobstruktion. Verh Dtsch Ges Inn Med 88: 245–252
Unzeitig JC, Richards W, Church JA (1983) Administration of metered-dose inhalers: comparison of openand closed-mouth techniques in childhood asthmatics. Ann Allergy 51 (6): 571–573
Vildgren MT, Paronen TP, Kärkkäinen A, Karjalainen P (1987) Effect of extension devices on the drug deposition from inhalation aerosols. Int J Pharm 39: 107–112
Walker SR, Evans ME, Richards AJ, Paterson JW (1972) The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 13 (6): 861–867
Warachit B (1988) Nosocomial pneumonia caused by contaminated Nebulizer. I Med Assoc Thai 71: 33–34
Weber RW, Petty WE, Nelson HS (1979) Aerosolized terbutaline in asthmatics–comparison of dosage strength, schedule, and method of administration. J Allergy Clin Immunol 63 (2): 116–121
Weeke ER (1982) Reported clinical experiences with inhaled terbutaline aerosol via spacer devices. Eur J Respir Dis [Suppl 119] 63: 105–109
Weinberg EG, Klein M (1988) Abuse of home nebulisers in asthma. S Afr J Med 74: 136–137
Wetterlin K (1988) Turbuhaler.A new powder inhaler for administration of drugs to the airways. Phamtaceutical Res 5 (8): 506–506
Wickramasinghe H, Liebeschuetz HJ (1983) (Correspondence) - Addiction to aerosol treatment. Br Med J 287: 1877
Yarbrough J, Mansfield LE, Ting S (1985) Metered dose inhaler induced bronchospasm in asthmatic patients. Ann Allergy 55: 25–27
Yu CP, Nicolaides P, Soong TT (1979) Effect of random airway sizes on aerosol deposition. Am Ind Hyg Assoc J 40: 999–1005
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Niggemann, B. (1989). Aerosoltherapie bei obstruktiven Atemwegserkrankungen: Deposition, Applikationsarten, Inhalationstechniken, Inhalationshilfen. In: Brandis, M., Frick, P., Kochsiek, K., Martini, G.A., Prader, A. (eds) Advances in Internal Medicine and Pediatrics / Ergebnisse der Inneren Medizin und Kinderheilkunde. Advances in Internal Medicine and Pediatrics / Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 59. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-52317-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-52317-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-52318-2
Online ISBN: 978-3-642-52317-5
eBook Packages: Springer Book Archive